Phase II study of VNP40101M for adults with recurrent malignant glioma No significant financial relationships to disclose. This is an ASCO Meeting Abstract from the 2005 ASCO Annual Meeting. This ...
The prevention of bleeding with adequately sustained levels of clotting factor, after a single therapeutic intervention and without the need for further medical intervention, represents an important ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback